The International Society for Infectious Diseases (ISID) and the Swiss
Society for Infectious Diseases (SSI) are inviting applications for their joint
Infectious Diseases Research Fellowship Program. The purpose of this programme
is to support infectious disease physicians and scientists from under-resourced
countries through multidisciplinary clinical and laboratory training at a
select biomedical institution in Zurich, Switzerland. The one-year SSI/ISID
Fellowship programme is open to applicants who are 40 years or younger,
citizens and permanent residents of under-resourced countries or Eastern
Europe. The deadline for applications is 16 June 2023.
More information: https://na.eventscloud.com/eSites/748378/Homepage
The MRCT Center and Medable convened a multi-stakeholder task force to address ethical and regulatory opportunities and challenges related to Decentralized Clinical Trials (DCTs). Join them on June 20, from 10 - 11 AM ET, for a joint webinar entitled, "Ethical Review of Decentralized Clinical Trials (DCTs): Tools, Resources & Best Practices."
During the webinar, Barbara Bierer (MRCT Center), Pam Tenaerts
(Medable) and Leanne Madre (Medable) will present a framework, recommendations,
and tools organized around 3 DCT domains: People, Remote Data Collection, and
Data Oversight. Best practices for the ethical review, approval, and conduct of
DCTs will be provided.
Clinical trial stakeholders (IRB/ECs,
HRPP, sites, sponsors, investigators, and others) to register for the webinar here
Many national regulatory agencies in sub-Saharan Africa, which have responsibility for drug safety, lack the expertise, critical mass and infrastructure to monitor drug safety effectively during clinical trials and after licensing. The PhArmacoVIgilance Africa (PAVIA) project, implemented during the period 2018-2022 in Eswatini, Ethiopia, Nigeria and Tanzania, set out to strengthen pharmacovigilance in the African context. PAVIA incorporated the lessons and best practices from the project into a 'Blueprint for strengthening pharmacovigilance systems in resource-limited countries', and published the project’s outputs on The Global Health Network.
Read the blueprint https://media.tghn.org/medialibrary/2023/05/Pavia_Blueprint_FINAL.pdf
Project outputs on The Global Health Network: https://globalpharmacovigilance.tghn.org/pavia/
Read moreMichelson Prizes Next Generation Grants are annual awards of $150,000, which support early-career investigators (35 years and under) who are working to significantly advance human immunology and vaccine and immunotherapy research for major global diseases. The research to be covered by the grant should aim at tackling the current roadblocks that exist in human vaccine development and expanding our limited understanding of key immune processes that are fundamental to successful vaccine and immunotherapy development. The Prizes are awarded by the Michelson Medical Research Foundation and the Human Immunome Project (formerly the Human Vaccines Project). Applications are being accepted with a deadline of 11 June 2023.
More information www.humanimmunomeproject.org/michelsonprizes
Read more